Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. This week, ...
Center for Devices and Radiological Health (CDRH) released a discussion paper proposing new approaches to regulating medical ...
The FDA is taking stock of the regulatory tools it will need for the next decade to keep up with AI and medical device ...
The U.S. Food and Drug Administration (FDA) released a discussion paper on Generative AI (GenAI)-enabled devices on Aug. 19, ...
BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it has completed its revised ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration's headquarters is in Silver Spring, Maryland. The Food and Drug Administration has released a ...
The US Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH), regulates medical devices and radiation-emitting products. 1 The 510(k) clearance process, ...
BioCardia Inc. (BCDA), a biotechnology company developing cellular and cell-derived therapies for cardiovascular and pulmonary diseases, has filed a revised De Novo pre-submission with the FDA for its ...
The U.S. Food and Drug Administration (FDA) has published its guidance agenda for Fiscal Year 2026, announcing plans for eight guidance documents to be released this upcoming year. It also named 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results